ES2083605T3 - 8-cloro-benzotiazepina - compuesto para profilaxis y tratamiento de discrasia de neurocitos cerebrales. - Google Patents

8-cloro-benzotiazepina - compuesto para profilaxis y tratamiento de discrasia de neurocitos cerebrales.

Info

Publication number
ES2083605T3
ES2083605T3 ES92103256T ES92103256T ES2083605T3 ES 2083605 T3 ES2083605 T3 ES 2083605T3 ES 92103256 T ES92103256 T ES 92103256T ES 92103256 T ES92103256 T ES 92103256T ES 2083605 T3 ES2083605 T3 ES 2083605T3
Authority
ES
Spain
Prior art keywords
dyscrasia
benzotiazepine
neurocytes
prophylaxis
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92103256T
Other languages
English (en)
Inventor
Sakae Murata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2083605T3 publication Critical patent/ES2083605T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE EXPONE UN AGENTE PROFILACTICO Y CURATIVO DE LAS SECUELAS DE LAS DISCRASIAS DE LOS NEUROCITOS CEREBRALES, QUE COMPRENDE UN COMPUESTO DE BENZOTIAZEPINA REPRESENTADO POR LA FORMULA: (DONDE R ELEVADO 1 A R ELEVADO 4 REPRESENTAN UN GRUPO ALCALINO BAJO) O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO COMO INGREDIENTE ACTIVO.
ES92103256T 1991-02-26 1992-02-26 8-cloro-benzotiazepina - compuesto para profilaxis y tratamiento de discrasia de neurocitos cerebrales. Expired - Lifetime ES2083605T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11706191 1991-02-26

Publications (1)

Publication Number Publication Date
ES2083605T3 true ES2083605T3 (es) 1996-04-16

Family

ID=14702461

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92103256T Expired - Lifetime ES2083605T3 (es) 1991-02-26 1992-02-26 8-cloro-benzotiazepina - compuesto para profilaxis y tratamiento de discrasia de neurocitos cerebrales.

Country Status (10)

Country Link
EP (1) EP0501442B1 (es)
JP (1) JPH0586043A (es)
KR (1) KR920016099A (es)
AT (1) ATE131057T1 (es)
CA (1) CA2061353A1 (es)
DE (1) DE69206447T2 (es)
DK (1) DK0501442T3 (es)
ES (1) ES2083605T3 (es)
FR (1) FR2673106B1 (es)
GR (1) GR3018320T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103816462A (zh) * 2012-11-16 2014-05-28 丁徽 一种治疗中风偏瘫的中药

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85257A (en) * 1987-02-10 1993-02-21 Tanabe Seiyaku Co Pharmaceutical compositions containing 2-(4-methoxyphenyl) 3-acetoxy-5-- (2-(dimethylamino) ethyl) -8-chloro-2,3- dihydro-1,5-benzothiazepin -4 (5h)-one having renal function-improving effect and diuretic effect
US4879289A (en) * 1988-05-24 1989-11-07 Marion Laboratories, Inc. Method of ameliorating epileptic seizures

Also Published As

Publication number Publication date
GR3018320T3 (en) 1996-03-31
EP0501442B1 (en) 1995-12-06
FR2673106A1 (fr) 1992-08-28
DE69206447D1 (de) 1996-01-18
DK0501442T3 (da) 1996-01-08
DE69206447T2 (de) 1996-06-05
ATE131057T1 (de) 1995-12-15
EP0501442A1 (en) 1992-09-02
CA2061353A1 (en) 1992-08-27
JPH0586043A (ja) 1993-04-06
KR920016099A (ko) 1992-09-24
FR2673106B1 (fr) 1995-06-16

Similar Documents

Publication Publication Date Title
FI950309A (fi) Proliiniamidijohdannaisia
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
NZ248099A (en) Use of spiro-oxathiolane quinuclidine derivatives for treating sjoegren syndrome
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
PT90034A (pt) Processo para a preparacao de tetra-hidroimidazo-{1,4}benzodiazepina-2-onas
ES2068216T3 (es) Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.
EP0257992A3 (en) Prophylactic and therapeutic agents for cerebral ischemia
ES2083605T3 (es) 8-cloro-benzotiazepina - compuesto para profilaxis y tratamiento de discrasia de neurocitos cerebrales.
ES552782A0 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
DK0420224T3 (da) Anthihepatopatisk middel
TW275629B (es)
IE873442L (en) Cephalosporin derivative
FR2598914B1 (fr) Composition prophylactique et curative pour l'arteriosclerose
ATE71364T1 (de) Fluor enthaltende vitamin-d2-derivate.
KR890009886A (ko) 심기능 부전의 예방 및 치료제
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
FI933652A0 (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 501442

Country of ref document: ES